Correlation Between Medicenna Therapeutics and Fennec Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Medicenna Therapeutics and Fennec Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medicenna Therapeutics and Fennec Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Medicenna Therapeutics Corp and Fennec Pharmaceuticals, you can compare the effects of market volatilities on Medicenna Therapeutics and Fennec Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medicenna Therapeutics with a short position of Fennec Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medicenna Therapeutics and Fennec Pharmaceuticals.

Diversification Opportunities for Medicenna Therapeutics and Fennec Pharmaceuticals

0.22

Correlation Coefficient

Medicenna Therapeutics  Fennec Pharmaceuticals

Modest diversification

The 3 months correlation between Medicenna and Fennec is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding Medicenna Therapeutics Corp and Fennec Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fennec Pharmaceuticals and Medicenna Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medicenna Therapeutics Corp are associated (or correlated) with Fennec Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fennec Pharmaceuticals has no effect on the direction of Medicenna Therapeutics i.e., Medicenna Therapeutics and Fennec Pharmaceuticals go up and down completely randomly.

Pair Corralation between Medicenna Therapeutics and Fennec Pharmaceuticals

Assuming the 90 days trading horizon Medicenna Therapeutics Corp is expected to generate 1.7 times more return on investment than Fennec Pharmaceuticals. However, Medicenna Therapeutics is 1.7 times more volatile than Fennec Pharmaceuticals. It trades about 0.05 of its potential returns per unit of risk. Fennec Pharmaceuticals is currently generating about 0.02 per unit of risk. If you would invest  51.00  in Medicenna Therapeutics Corp on March 6, 2025 and sell it today you would earn a total of  45.00  from holding Medicenna Therapeutics Corp or generate 88.24% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	99.78%
Values	Daily Returns

Medicenna Therapeutics Corp  vs.  Fennec Pharmaceuticals

Medicenna Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Medicenna Therapeutics Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Medicenna Therapeutics is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Fennec Pharmaceuticals

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Fennec Pharmaceuticals are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Fennec Pharmaceuticals displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Medicenna Therapeutics and Fennec Pharmaceuticals

The main advantage of trading using opposite Medicenna Therapeutics and Fennec Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medicenna Therapeutics position performs unexpectedly, Fennec Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fennec Pharmaceuticals will offset losses from the drop in Fennec Pharmaceuticals' long position.

The idea behind Medicenna Therapeutics Corp and Fennec Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..